Abstract:Objective To evaluate the value of transrectal ultrasound-guided systematic prostate biopsy and magnetic resonance imaging(MRI) suspicious targeted biopsy in the biopsy of prostate cancer.Methods A retrospective analysis was performed in 181 patients with suspected prostate cancer underwent transrectal ultrasound-guided prostate biopsy from September 2011 to September 2013 in the Second Affiliated Hospital of Zhejiang University School of Medicine.In all the 181 patients had the transrectal ultrasound-guided systematic biopsy,116 patients with suspicious MRI had two additional targeted biopsies.Prostate cancers were detected in 97 of 181 patients,and the prostatic hyperplasia were detected in 84 patients.The detection rate of transrectal ultrasound-guided systematic prostate biopsy,suspicious MRI targeted biopsy and combined biopsy in prostate cancer were tested by χ2 test.Compared with pathological results,the sensitivity,specificity,accuracy,positive predictive value and negative predictive value of transrectal ultrasound-guided systematic prostate biopsy and suspicious MRI targeted biopsy were calculated and tested by χ2 test.Results Prostate cancer was detected in 97 of 181 patients(53.6%),63(34.8%) was detected by transrectal ultrasound-guided systematic prostate biopsy,and 81(44.8%) was detected by suspicious MRI targeted biopsy.The suspicious MRI targeted biopsy detected more prostate cancers which there had statistical differences compared with transrectal ultrasound-guided systematic prostate biopsy(χ2=34.830,P=0.015).Transrectal ultrasound guided prostate systematic biopsy missed 34 cases of prostate cancer,and suspicious MRI targeted biopsy missed 16 cases,accounting for 35.1%(34/97) and 16.5%(16/97) of prostate cancer.The 181 patients were biopsied a total of 1 896 cores,including transrectal ultrasound guided systematic biopsy 1 448 cores and suspicious MRI targeted biopsy 448 cores.The sensitivity,specifi city,positive predictive value and negative predictive value of suspicious MRI targeted biopsy was 89.8%(280/312),87.4%(1 384/1 584),58.3%(280/480),97.7%(1 384/1 416) compared with the sensitivity of 71.8%(224/312),specifi city of 22.7%(360/1 584),positive predictive value of 15.5%(224/1 448) and negative predictive value of 80.4%(360/448) in transrectal ultrasound-guided systematic prostate biopsy(χ2=14.008,96.037,143.049,170.729,all P < 0.001).Conclusions The detection rate of prostate cancer of suspicious MRI targeted biopsy is higher than transrectal ultrasound-guided systematic prostate biopsy,but can′t replace transrectal ultrasound-guided systematic prostate biopsy.The two methods are complementary to improve the prostate cancer detection rate.

Evaluation of multiparametric MRI in predicting seminal vesicle invasion of prostate cancer

Can 3D Multiparametric Ultrasound Imaging Predict Prostate Biopsy Outcome?

The value of transrectal ultrasound-guided systematic prostate biopsy and additional targeted cores from suspicious magnetic resonance imaging in the biopsy of prostate cancer

Accuracy of MRI in detecting seminal vesicle invasion in prostate cancer: a systematic review and meta-analysis

The Sensitivity and Specificity of Multiparametric Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Predicting Seminal Vesicle Invasion in Clinically Significant Prostate Cancer: A Multicenter Retrospective Study

The value of multiparametric MRI for predicting prostate cancer extracapsular extension

Values of multiparametric and biparametric MRI in diagnosing clinically significant prostate cancer: a multivariate analysis

Evaluation of Multiparametric Magnetic Resonance Imaging in Detection and Prediction of Prostate Cancer.

The Role of Multiparametric MRI (mpMRI) in the Prediction of Adverse Prostate Cancer Pathology in Radical Prostatectomy Specimen

Detection rate and characteristics of prostate cancer foci on multi-parametric MRI (mp-MRI) using whole mount section as a reference standard-a single center clinical study

Real-time precision targeted prostate biopsy using transrectal ultrasound-magnetic resonance fusion

The value of multiparametric MRI examination using 1.5T and 3.0T with PI-RADS (version 2) in the qualitative diagnosis of clinically significant prostate cancer

Prebiopsy Mp-Mri Can Help to Improve the Predictive Performance in Prostate Cancer: A Prospective Study in 1,478 Consecutive Patients.

Predictive Model Containing PI-RADS V2 Score for Postoperative Seminal Vesicle Invasion among Prostate Cancer Patients

[Application of Artificial Intelligence Combined with Multi-Parametric MRI in the Early Diagnosis of Prostate Cancer].

The Combined Value of Mpus and Mpmri-Trus Fusion for the Diagnosis of Clinically Significant Prostate Cancer.

Diagnostic accuracy and discriminative power of biparametric versus multiparametric MRI in predicting muscle-invasive bladder cancer

Comparison of 68 Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and multi-parametric magnetic resonance imaging (MRI) in the evaluation of tumor extension of primary prostate cancer.

Improving diagnostic efficacy of primary prostate cancer with combined 99mTc-PSMA SPECT/CT and multiparametric-MRI and quantitative parameters

Computer-aided detection of prostate cancer in early stages using multi-parameter MRI: A promising approach for early diagnosis

Diagnostic Performance of Multiparametric MRI Parameters for Gleason Score and Cellularity Metrics of Prostate Cancer in Different Zones: a Quantitative Comparison